Tyrosine Kinase Inhibitor

SEATTLE — In this video from the ARVO meeting, Jay Chhablani, MD, discusses data on pan-VEGF blockers and tyrosine kinase inhibitors for age-related macular degeneration.

SAN DIEGO — Healio spoke with Kathryn Dao, MD, about a study assessing the effects of tapering to withdraw of TNF inhibitors compared with stable use among patients with rheumatoid arthritis.

SAN DIEGO — Kathryn Dao, MD, discusses a study presented at ACR Convergence 2023 that compared the initiation of TNF inhibitors with non-TNF inhibitor biologics or JAK inhibitors among patients with rheumatoid arthritis-associated interstitial lung disease.

MADRID — In a video interview with Healio, Sumanta (Monty) Pal, MD, FASCO, spoke about the STELLAR-304 clinical trial for patients with non-clear cell renal cell carcinoma at ESMO Congress.

Healio spoke with Gwen Nichols, MD, to discuss survivorship in CML patients.

Healio spoke with Gwen Nichols, MD, to discuss how to approach CML treatment in pediatric patients.

Healio spoke with Gwen Nichols, MD, about treatment options currently available in CML.

In this Healio Video Perspective, Sophie J. Bakri, MD, discusses data presented at the Retina Society meeting that investigated the antiangiogenic profiles of three tyrosine kinase inhibitors: vorolanib, axitinib and sunitinib.

In this video, Diana Do, MD, Professor of Ophthalmology at the Stanford University School of Medicine, discusses the 'bright future' for DME treatment with new drugs coming down the pipeline.